When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Ingestões comuns de plantas tóxicas

Last reviewed: 20 Aug 2025
Last updated: 10 Apr 2024

Summary

Definition

Anamnesis y examen

Principales factores de diagnóstico

  • presença de fatores de risco
  • taquicardia
  • hipertensão
  • hipotensão
  • miose
  • midríase
  • bradicardia
  • estado mental alterado
  • alucinações
  • convulsões
Todos los datos

Otros factores de diagnóstico

  • náuseas
  • vômitos
  • dor abdominal
  • diarreia
  • dispneia
  • rubor cutâneo
  • dermatite
  • irritação dermatológica/da mucosa
  • sangramento visível: epistaxe, melena, hematúria, hematêmese, hemoptise
  • cefaleia
  • dor torácica
  • dor/inchaço muscular
  • palidez cutânea
  • hematomas frequentes
  • sangramento petequial
  • icterícia
  • asterixis (flapping)
  • ascite
  • eritema palmar
  • aranhas vasculares
  • diaforese
  • pele ressecada
  • febre
  • retenção urinária
  • constipação
  • hiperventilação
  • fasciculações
  • fraqueza neuromuscular
  • alterações sensitivas
Todos los datos

Factores de riesgo

  • forrageamento de plantas selvagens para comer
  • preparação de chás com plantas selvagens
  • suspeita ou confirmação de ingestão de plantas por crianças
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • eletrocardiograma (ECG)
  • Hemograma completo
  • eletrólitos séricos
  • creatinina sérica
  • lactato sérico
  • ureia/creatinina sérica
  • testes da função hepática
  • razão normalizada internacional (INR)
  • gasometria arterial
  • radiografia torácica
Todos los datos

Pruebas diagnósticas que deben considerarse

  • troponina
  • níveis de digoxina sérica
  • resposta à fisostigmina
Todos los datos

Algoritmo de tratamiento

Agudo

todos os pacientes

Colaboradores

Autores

Susan Smolinske, PharmD, DABAT, FAACT

Clinical Consultant

New Mexico Poison and Drug Information Center

Adjunct Professor

Pharmacy Practice and Administrative Sciences

University of New Mexico

Albuquerque

NM

Divulgaciones

SS is a member of the ToxED advisory board and consults with webPOISONCONTROL.

Cynthia K. Aaron, MD

Medical Director

Program Director Medical Toxicology

Regional Poison Center at Children's Hospital of Michigan

Professor of Emergency Medicine and Pediatrics

Wayne State University School of Medicine

Detroit

MI

Divulgaciones

CKA owns personal stock in Merck. CKA was on the State of Michigan Public Health Advisory Council for 3 years, and consults with RubiconMD.

Agradecimientos

Dr Susan Smolinske and Dr Cynthia K. Aaron would like to gratefully acknowledge Dr Gerald F. O'Malley and Dr Rika N. O'Malley, previous contributors to this topic. GFOM and RNOM declare that they have no competing interests.

Divulgaciones

GFOM and RNOM declare that they have no competing interests.

Revisores por pares

Jessamine Soderstrom, MD, MBBS, FACEM

Clinical Toxicologist

Emergency Consultant

Emergency Department

Royal Perth Hospital

Perth

Australia

Divulgaciones

JS declares that she has no competing interests.

Scott Phillips, MD

Clinical Faculty

Department of Toxicology

Rocky Mountain Poison & Drug Center

Denver

CO

Divulgaciones

SP declares that he has no competing interests.

Judith Alsop, PharmD, DABAT

Poison Center Director

California Poison Control System, Sacramento Division

University of California Davis Medical Center

Sacramento

Associate Clinical Professor of Pharmacy

University of California San Francisco School of Pharmacy

San Francisco

Clinical Professor of Medicine

Volunteer Clinical Faculty

University of California Davis School of Medicine

Sacramento

CA

Divulgaciones

JA declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Froberg B, Ibrahim D, Furbee RB. Plant poisoning. Emerg Med Clin North Am. 2007 May;25(2):375-433. Resumen

Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther. 2004 May;102(2):131-8. Resumen

Gowdy JM. Stramonium intoxication: review of symptomatology in 212 cases. JAMA. 1972 Aug 7;221(6):585-7. Resumen

Burkhard PR, Burkhardt K, Haenggeli CA, et al. Plant-induced seizures: reappearance of an old problem. J Neurol. 1999 Aug;246(8):667-70. Resumen

Gummin DD, Mowry JB, Beuhler MC, et al. 2022 Annual report of the National Poison Data System(®) (NPDS) from America's Poison Centers(®): 40th annual report. Clin Toxicol (Phila). 2023 Oct;61(10):717-939.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

Use of this content is subject to our disclaimer